Plant-based vaccines for Alzheimer's disease (Q92690202)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31189781%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

review article

2 references

2 October 2020

Plant-based vaccines for Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31189781%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

2 October 2020

1 reference

2 October 2020

Shoichi Ishiura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31189781%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Taiji Yoshida

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31189781%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

publication date

1 January 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31189781%20AND%20SRC:MED&resulttype=core&format=json

Proceedings of the Japan Academy, Series B

1 May 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31189781%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

2 October 2020

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31189781%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31189781%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

page(s)

290-294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31189781%20AND%20SRC:MED&resulttype=core&format=json

Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options

1 May 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Alzheimer's disease: The right drug, the right time

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Alzheimer's disease: Only prevention makes sense

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Active Vaccines for Alzheimer Disease Treatment.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Future directions in Alzheimer's disease from risk factors to prevention

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

A phase 3 trial of semagacestat for treatment of Alzheimer's disease

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Effect of rice-expressed amyloid β in the Tg2576 Alzheimer's disease transgenic mouse model.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Transgenic rice expressing amyloid β-peptide for oral immunization

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Production of anti-amyloid β antibodies in mice fed rice expressing amyloid β.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Reduction of amyloid beta-peptide accumulation in Tg2576 transgenic mice by oral vaccination

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Lessons from the 'Humanitarian Golden Rice' project: regulation prevents development of public good genetically engineered crop products

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer's disease

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Transgenic potato expressing Abeta reduce Abeta burden in Alzheimer's disease mouse model

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Evaluation of the safety and immunogenicity of synthetic A 42 (AN1792) in patients with AD

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Expression of amyloid-beta 1-40 and 1-42 peptides in Capsicum annum var. angulosum for oral immunization.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6751297

11 February 2021

Identifiers

DOI

10.2183/PJAB.95.020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31189781%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31189781%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

PubMed publication ID

31189781

1 reference